Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
117M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
16.5M
-
Shares change
-
+374K
-
Total reported value, excl. options
-
$174M
-
Value change
-
+$3.04M
-
Number of buys
-
42
-
Number of sells
-
-22
-
Price
-
$10.56
Significant Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q1 2016
79 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share as of Q1 2016.
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.5M shares
of 117M outstanding shares and own 14.1% of the company stock.
Largest 10 shareholders include TPG Group Holdings (SBS) Advisors, Inc. (2.38M shares), FMR LLC (1.68M shares), Pennant Capital Management, LLC (1.36M shares), JPMORGAN CHASE & CO (1.29M shares), TimesSquare Capital Management, LLC (1.19M shares), VANGUARD GROUP INC (943K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (923K shares), WELLS FARGO & COMPANY/MN (886K shares), GOLDMAN SACHS GROUP INC (885K shares), and PERCEPTIVE ADVISORS LLC (619K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.